1. Home
  2. CVAC vs PL Comparison

CVAC vs PL Comparison

Compare CVAC & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • PL
  • Stock Information
  • Founded
  • CVAC 2000
  • PL 2010
  • Country
  • CVAC Germany
  • PL United States
  • Employees
  • CVAC N/A
  • PL N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • PL Aerospace
  • Sector
  • CVAC Health Care
  • PL Industrials
  • Exchange
  • CVAC Nasdaq
  • PL Nasdaq
  • Market Cap
  • CVAC 818.8M
  • PL 947.7M
  • IPO Year
  • CVAC 2020
  • PL N/A
  • Fundamental
  • Price
  • CVAC $3.12
  • PL $3.23
  • Analyst Decision
  • CVAC Buy
  • PL Buy
  • Analyst Count
  • CVAC 2
  • PL 11
  • Target Price
  • CVAC $10.00
  • PL $5.53
  • AVG Volume (30 Days)
  • CVAC 717.4K
  • PL 5.0M
  • Earning Date
  • CVAC 04-10-2025
  • PL 06-05-2025
  • Dividend Yield
  • CVAC N/A
  • PL N/A
  • EPS Growth
  • CVAC N/A
  • PL N/A
  • EPS
  • CVAC 0.75
  • PL N/A
  • Revenue
  • CVAC $554,073,921.00
  • PL $244,352,000.00
  • Revenue This Year
  • CVAC N/A
  • PL $14.08
  • Revenue Next Year
  • CVAC $66.34
  • PL $21.49
  • P/E Ratio
  • CVAC $4.19
  • PL N/A
  • Revenue Growth
  • CVAC 895.54
  • PL 10.72
  • 52 Week Low
  • CVAC $2.22
  • PL $1.67
  • 52 Week High
  • CVAC $5.28
  • PL $6.71
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 53.48
  • PL 41.29
  • Support Level
  • CVAC $3.05
  • PL $3.06
  • Resistance Level
  • CVAC $3.02
  • PL $3.33
  • Average True Range (ATR)
  • CVAC 0.19
  • PL 0.32
  • MACD
  • CVAC 0.06
  • PL 0.03
  • Stochastic Oscillator
  • CVAC 79.14
  • PL 47.31

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.

Share on Social Networks: